California-based Atara Biotherapeutics (Nasdaq: ATRA) revealed that the US Food and Drug Administration (FDA) has lifted the ...

Lossmaking Danish pharma ingredients maker Xellia Pharmaceuticals said it could only survive against Chinese competition by ...

The US Food and Drug Administration (FDA) announced its intent to expand the use of unannounced inspections at foreign ...

The Russian government will consider registering next-in-class drugs based on data from the second phase of clinical trials ...

US biotech Aldeyra Therapeutics is making another attempt to gain marketing approval for its eye drop treatment reproxalap, a ...

Vertex Pharmaceuticals missed Wall Street estimates for the first quarter of 2025, as sales of its cystic fibrosis (CF) ...

Privately-held Alchemab Therapeutics, a biotech that uses the power of human immune evolution to identify and develop ...

US pharma major Bristol Myers Squibb (NYSE: BMY) is set to lay off another 516 employees at its New Jersey, USA site, ...

US healthcare giant Johnson & Johnson has presented data from its Phase III LUMEOS study and disclosed that the trial did not ...

Some $45 million has been raised in a Series B financing round by Nuevocor, an IND-stage biotech developing therapies for ...

US investment firm Deerfield Management has closed its latest fund with $600 million in commitments to support advances in ...

USA-based rare disease drug developer PTC Therapeutics (Nasdaq: PTCT) on Monday announced results from the Phase II PIVOT-HD ...